Sleight B J, Prasad V S, DeLaat C, Steele P, Ballard E, Arceci R J, Sidman C L
Department of Pediatrics, Children's Hospital Medical Center, Cincinnati, OH, USA.
Bone Marrow Transplant. 1998 Aug;22(4):375-80. doi: 10.1038/sj.bmt.1701306.
This report describes a child with a severe phenotype of autoimmune lymphoproliferative syndrome (ALPS) who developed progressive disease requiring stem cell transplantation. This severe form of ALPS was associated with a novel Fas gene splice site mutation that resulted in functional deletion of exons 8 and 9. While this child shared many clinical features with previously described ALPS cases, including massive lymphadenopathy and circulating alphabeta+ CD3+CD4-CD8-T cells, his disease progressed despite immunosuppressive therapy to a clinically aggressive oligoclonal lymphoproliferation which resembled a diffuse large cell non-Hodgkin's lymphoma. After partial remission was achieved with cytotoxic therapy the patient underwent BMT from an unrelated donor. This is the first reported case of ALPS in which BMT was successfully attempted for correction of a Fas deficiency.
本报告描述了一名患有自身免疫性淋巴细胞增生综合征(ALPS)严重表型的儿童,其病情进展,需要进行干细胞移植。这种严重形式的ALPS与一种新的Fas基因剪接位点突变有关,该突变导致外显子8和9功能缺失。虽然这名儿童与先前描述的ALPS病例有许多临床特征相同,包括巨大淋巴结病和循环中的αβ + CD3 + CD4 - CD8 - T细胞,但尽管进行了免疫抑制治疗,其病情仍进展为临床侵袭性寡克隆淋巴细胞增生,类似于弥漫性大细胞非霍奇金淋巴瘤。在通过细胞毒性疗法实现部分缓解后,患者接受了来自无关供体的骨髓移植。这是首次报道成功尝试通过骨髓移植纠正Fas缺陷的ALPS病例。